tiprankstipranks
Heidelberg Pharma AG (DE:HPHA)
XETRA:HPHA
Germany Market
HPHA
Heidelberg Pharma AG
RESEARCH TOOLSreports

Heidelberg Pharma AG (HPHA) Financial Statements

6 Followers

Heidelberg Pharma AG Financial Overview

Heidelberg Pharma AG's market cap is currently €130.53M. The company's EPS TTM is €; its P/E ratio is -3.18; Heidelberg Pharma AG is scheduled to report earnings on March 26, 2026, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Nov 25Feb 25Feb 24Feb 23Feb 22
Income Statement
Total Revenue€ 1.46M€ 6.85M€ 9.86M€ 18.51M€ 1.75M
Gross Profit€ -1.63M€ 4.20M€ 6.61M€ 13.83M€ -2.96M
Operating Income€ -47.44M€ -24.56M€ -21.21M€ -18.33M€ -25.63M
EBITDA€ -44.63M€ -18.37M€ -18.71M€ -16.19M€ -24.83M
Net Income€ -42.28M€ -19.38M€ -20.35M€ -19.70M€ -26.63M
Balance Sheet
Cash & Short-Term Investments€ 14.98M€ 29.42M€ 43.44M€ 81.33M€ 6.14M
Total Assets€ 38.14M€ 60.72M€ 70.35M€ 100.58M€ 21.73M
Total Debt€ 1.16M€ 21.97M€ 5.83M€ 15.98M€ 10.63M
Net Debt€ -13.81M€ -7.45M€ -37.61M€ -65.35M€ 4.49M
Total Liabilities€ 49.05M€ 29.85M€ 21.01M€ 33.94M€ 15.03M
Stockholders' Equity€ -10.92M€ 30.87M€ 49.34M€ 66.64M€ 6.70M
Cash Flow
Free Cash Flow€ -31.73M€ -30.04M€ -34.63M€ -9.48M€ -28.00M
Operating Cash Flow€ -31.60M€ -29.59M€ -33.67M€ -8.86M€ -26.61M
Investing Cash Flow€ -135.05K€ -449.13K€ 5.85M€ -597.57K€ -1.40M
Financing Cash Flow€ 18.35M€ 16.08M€ -10.05M€ 84.00M€ 29.17M
Currency in EUR

Heidelberg Pharma AG Earnings and Revenue History

Income Statement >

Heidelberg Pharma AG Debt to Assets

Balance Sheet >

Heidelberg Pharma AG Cash Flow

Cash Flow >

Heidelberg Pharma AG Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
Earnings >